“And honestly, the results were very clear: They think schools should focus on core subject areas,” Byler said. “You see some level of support for this across all kinds of different demographics where ...
Current share price of US$483 suggests Vertex Pharmaceuticals is potentially 44% undervalued Analyst price target for VRTX is US$509 which is 40% below our fair value estimate ...